# The Everolimus-Transplant Exit Strategy Trial (E-TEST)

> **NCT01636466** · PHASE3 · TERMINATED · sponsor: **Ashtar Chami** · enrollment: 1 (actual)

## Conditions studied

- Kidney Failure, Chronic

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT01636466
- **Lead sponsor:** Ashtar Chami
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-06
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Feasibility
- **Last updated:** 2018-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01636466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01636466, "The Everolimus-Transplant Exit Strategy Trial (E-TEST)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01636466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*